The FDA just approved a new type of pain medication, and it's a non-opioid called suzetrigine that stops body pain at its ...
The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or ...
The medication offers relatively modest pain relief, underscoring the challenges of finding new ways to manage pain.
Suzetrigine prevents pain signals from reaching the brain and doesn't give an opioid-like high, making it non-addictive—but ...
The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...
The drug offered more relief than a placebo in clinical trials, though it does not appear more effective than other pain ...
Related: Ozempic-style drugs tied to more than 60 health benefits and risks in biggest study-of-its-kind Opioid addiction, or ...
SB5, an adalimumab biosimilar approved in the US, is showing to be safe and effective for patients with psoriasis in the long ...
Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...
Sen. Will Parkinson introduced a bill that seeks to provide emergency contraception or “morning-after pill” to rape survivors as an option. It would still be up to the rape survivors to decide ...